Tag Archives: ACHC

Acadia Healthcare (NASDAQ:ACHC) Offering 10.6 Million shares at $22.50; Stock Plunges in Premarket Trading – ACHC, UHS, PPHM, ACRX, JNJ, PFE, AMRN, BSX

Posted on December 7, 2012 by Geoff Noir

The Franklin, Tennessee based Acadia Healthcare Company Inc (NASDAQ:ACHC) offering of 10.6 million shares priced at a 1.5 percent discount of Thursday’s finish.

Acadia Healthcare stock plunged 9 cents premarket at $22.75, more than the offering price of $22.50.

The …

Posted in Healthcare, Latest Headlines | Tagged Acadia Healthcare, AcelRx Pharmaceuticals, ACHC, ACRX, Amarin, AMRN, Boston Scientific, BSX, JNJ, Johnson & Johnson, NASDAQ:ACHC, NASDAQ:ACRX, NASDAQ:AMRN, NASDAQ:PPHM, NYSE:BSX, NYSE:JNJ, NYSE:PFE, NYSE:UHS, Peregrine Pharmaceuticals, PFE, Pfizer, PPHM, UHS, Universal Health | Comments Off

Sanofi’s (NYSE:SNY) Genzyme Division Gets Approval for Thyrogen – SNY, MRK, PFE, GALE, ACRX, JNJ, ACHC, SRPT, ABT

Posted on December 7, 2012 by Thomas Vedder

Sanofi’s(NYSE:SNY) Genzyme division has got European Commission authorization of a product label development for the use of Thyrogen, its cure for thyroid cancer.

Thyrogen is used to cure patients with well-distinguished thyroid cancer. The drug is accepted as an adjunctive …

Posted in Healthcare, Latest Headlines | Tagged Abbott Laboratories, ABT, Acadia Healthcare, AcelRx Pharmaceuticals, ACHC, ACRX, GALE, Galena Biopharma, JNJ, Johnson, Merck, MRK, NASDAQ:ACHC, NASDAQ:ACRX, NASDAQ:GALE, NASDAQ:SRPT, NYSE:ABT, NYSE:JNJ, NYSE:MRK, NYSE:PFE, NYSE:SNY, PFE, Pfizer, Sanofi, Sarepta Therapeutics, SNY, SRPT | Comments Off

Healthcare Sector Quick Snapshot; Edwards Lifesciences (EW) Guidance Tops Analysts Views while Acadia Healthcare (ACHC) Proposes Share Offering – EW, ACHC, PFE, CYNO, YDNT, NXTM

Posted on December 5, 2012 by Thomas Vedder

Healthcare sector responded positively on Tuesday’s trading session and sector moved up +0.27%. If we look at the key movers of the sector so Cynosure, Inc (NASDAQ:CYNO) and Young Innovations, Inc (NASDAQ:YDNT) were major percentage gainer while key percentage Losers …

Posted in Healthcare, Latest Headlines | Tagged Acadia Healthcare, ACHC, CYNO, Cynosure, Edwards Lifesciences, EW, NASDAQ:ACHC, NASDAQ:CYNO, NASDAQ:NXTM, NASDAQ:YDNT, NxStage Medical, NXTM, NYSE:EW, NYSE:PFE, PFE, Pfizer, YDNT, Young Innovations | Comments Off

Acadia Healthcare (NASDAQ:ACHC) Unveils 9.6 Million Share Offering to Fund Acquisitions – ACHC, UHS, FB, PFE, GALE, JNJ, HOLX, PPHM, DVAX

Posted on December 4, 2012 by Geoff Noir

Acadia Healthcare Company Inc (NASDAQ:ACHC) has announced a 9.6 million share offering as the company looks to raise proceeds to support purchases.

The behavioral-health services company will offer 6 million shares, while the rest will be offered by certain selling …

Posted in Healthcare, Latest Headlines | Tagged Acadia Healthcare, ACHC, DVAX, Dynavax, Facebook, FB, GALE, Galena, Hologic, HOLX, JNJ, Johnson, NASDAQ:ACHC, NASDAQ:DVAX, NASDAQ:FB, NASDAQ:GALE, NASDAQ:HOLX, NASDAQ:PPHM, NYSE:JNJ, NYSE:PFE, NYSE:UHS, Peregrine Pharmaceuticals, PFE, Pfizer, PPHM, UHS, Universal Health Services | Comments Off

Acadia Healthcare Co. Inc. (NASDAQ:ACHC) Inked Deals to Buy Eight Facilities – ACHC, FB, UHS, PPHM, MYL, ZLCS, PFE, MRK, ARNA

Posted on November 27, 2012 by Thomas Vedder

Acadia Healthcare Co. Inc. (NASDAQ:ACHC)reported that it had inked two contracts to purchase an overall eight inpatient psychiatric facilities with almost 600 beds, as the firm tries to considerably expand its beds in operation and make its initial entry into …

Posted in Healthcare, Latest Headlines | Tagged Acadia Healthcare, ACHC, arena, ARNA, Facebook, FB, Merck, MRK, MYL, Mylan, NASDAQ:ACHC, NASDAQ:ARNA, NASDAQ:FB, NASDAQ:MYL, NASDAQ:PPHM, NASDAQ:ZLCS, NYSE:MRK, NYSE:PFE, NYSE:UHS, Peregrine, PFE, Pfizer, PPHM, UHS, Universal Health Services, Zalicus, ZLCS | Comments Off

Healthcare Sector; DaVita and HealthCare Partners Unveils Merger- DVA, NBS, HLS, MD, ACHC, BEAT, HGR

Posted on May 21, 2012 by Geoff Noir

DaVita Inc. (NYSE: DVA) and HealthCare Partners declared on Monday that they have signing a definitive merger contract. The two firms expect to close the transaction early in the Q4 of present year. Upon closing, the joint firm will be …

Posted in Reports | Tagged Acadia, ACHC, BEAT, Cardionet, DaVita, DVA, Hanger Orthopedic, HEALTHSOUTH, HGR, HLS, MD, Mednax, NASDAQ:ACHC, NASDAQ:BEAT, NBS, Neostem, NYSE:DVA, NYSE:HGR, NYSE:HLS, NYSE:MD, NYSEAMEX:NBS | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.